Conducting Competitive Intelligence on a Budget, Across Multiple Functions for Product Success & Sifting through Data for New Product Planning Decision Making
Pharmaceutical and biotechnology companies throughout the country are consistently working to evaluate and plan for new product introductions, weighing the scientific and marketing aspects of each new potential product candidate. Utilizing increasingly complex methods to evaluate competitive marketing and scientific information collected from numerous sources, executives in new product planning and competitive intelligence have their work cut out for them. As the market continues to increase in competitiveness and profit margins continue to retract, it is more important than ever for pharmaceutical companies to truly appreciate and invest in new product planning initiatives. This program will provide executives with a forum for frank discussion and considerations surrounding competitive intelligence and new product planning, specific to the pharmaceutical and biotech industries, which will ultimately assist corporations in making the best potential decisions regarding new product introductions.